Camber Capital Management as of Dec. 31, 2015
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 45 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | 7.6 | $118M | 1.8M | 65.64 | |
| Spdr S&p 500 Etf (SPY) | 6.6 | $102M | 500k | 203.87 | |
| Genomic Health | 5.6 | $87M | 2.5M | 35.20 | |
| Medicines Company | 5.3 | $82M | 2.2M | 37.34 | |
| Livanova Plc Ord (LIVN) | 4.6 | $71M | 1.2M | 59.37 | |
| AstraZeneca (AZN) | 4.4 | $68M | 2.0M | 33.95 | |
| Hca Holdings (HCA) | 4.4 | $68M | 1.0M | 67.63 | |
| Mylan Nv | 4.4 | $68M | 1.3M | 54.07 | |
| NuVasive | 3.9 | $60M | 1.1M | 54.11 | |
| Nektar Therapeutics (NKTR) | 3.8 | $59M | 3.5M | 16.85 | |
| Orthofix International Nv Com Stk | 3.8 | $59M | 1.5M | 39.21 | |
| Regeneron Pharmaceuticals | 3.5 | $54M | 100k | 542.87 | |
| Select Medical Holdings Corporation (SEM) | 3.5 | $54M | 4.5M | 11.91 | |
| Tenet Healthcare Corporation | 2.9 | $46M | 1.5M | 30.30 | |
| Quest Diagnostics Incorporated (DGX) | 2.8 | $43M | 600k | 71.14 | |
| Brookdale Senior Living (BKD) | 2.7 | $42M | 2.3M | 18.46 | |
| Masimo Corporation (MASI) | 2.7 | $42M | 1.0M | 41.51 | |
| Universal American | 2.7 | $41M | 5.9M | 7.00 | |
| Mead Johnson Nutrition | 2.5 | $40M | 500k | 78.95 | |
| Communications Sys | 2.5 | $39M | 2.6M | 15.12 | |
| Laboratory Corp. of America Holdings | 2.4 | $37M | 300k | 123.64 | |
| Bristol Myers Squibb (BMY) | 2.2 | $34M | 500k | 68.79 | |
| Ariad Pharmaceuticals | 2.2 | $34M | 5.4M | 6.25 | |
| Sequenom | 1.8 | $28M | 17M | 1.64 | |
| Arena Pharmaceuticals | 1.3 | $20M | 11M | 1.90 | |
| Invitae (NVTAQ) | 1.1 | $17M | 2.0M | 8.21 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $16M | 500k | 32.40 | |
| Protalix BioTherapeutics | 0.9 | $14M | 13M | 1.02 | |
| Ldr Hldg | 0.9 | $13M | 533k | 25.11 | |
| DURECT Corporation | 0.9 | $13M | 6.0M | 2.21 | |
| OraSure Technologies (OSUR) | 0.8 | $13M | 2.0M | 6.44 | |
| Syneron Medical Ltd ord | 0.8 | $12M | 1.5M | 7.71 | |
| BioScrip | 0.7 | $11M | 6.0M | 1.75 | |
| Innocoll | 0.6 | $9.2M | 1.1M | 8.30 | |
| Catabasis Pharmaceuticals | 0.5 | $7.9M | 1.0M | 7.93 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.4 | $6.1M | 9.0M | 0.68 | |
| Epirus Biopharmaceuticals In | 0.4 | $5.7M | 1.8M | 3.09 | |
| GenMark Diagnostics | 0.3 | $5.0M | 649k | 7.76 | |
| Biolase Technology | 0.3 | $4.5M | 5.3M | 0.84 | |
| AngioDynamics (ANGO) | 0.2 | $3.0M | 243k | 12.14 | |
| Targacept Inc Conv Dtd convertible | 0.1 | $1.7M | 1.7M | 1.00 | |
| Unilife US | 0.1 | $1.4M | 2.8M | 0.50 | |
| Health Care SPDR (XLV) | 0.1 | $1.2M | 17k | 72.04 | |
| Cardica | 0.1 | $1.3M | 8.4M | 0.15 | |
| Biolase Inc warrants | 0.0 | $18k | 1.8M | 0.01 |
